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Using deep sequencing technology, methods based on the sporadic
acquisition of somatic DNA mutations in human tissues have been
used to trace the clonal evolution of progenitor cells in diseased
states. However, the potential of these approaches to explore cell
fate behavior of normal tissues and the initiation of preneoplasia
remain underexploited. Focusing on the results of a recent deep se-
quencing study of eyelid epidermis, we show that the quantitative
analysis of mutant clone size provides a general method to resolve
the pattern of normal stem cell fate, and to detect and character-
ize the mutational signature of rare field transformations in human
tissues, with implications for the early detection of preneoplasia.
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Advances in genetic lineage tracing in transgenic animal mod-
els have provided important insights into the proliferative po-
tential and fate behavior of stem and progenitor cell popula-
tions in normal tissues [1, 2]. As well as providing constraints
on the mechanisms that regulate stem cell self-renewal, these
approaches have established a quantitative framework to ad-
dress tumor initiation and progression [3, 4, 5, 6]. However,
studies based on the clonal activation of oncogenes in animal
models can fail to recapitulate the natural processes that lead
to neoplasia in human tissues. In recent years, there has been
increasing emphasis on the characterization of cancer genomes
in human tissues and their potential to elucidate the pathways
involved in tumor progression [7, 8, 9, 10, 11, 12, 13, 14]. Al-
though these studies have revealed a range of cancer genes [15],
the heterogeneity and evolutionary diversity of the tumor en-
vironment make the separation of driver and passenger muta-
tions challenging.
Against the trend to focus human tumor samples, a recent
study has employed ultra-deep exome sequencing to determine
the mutational profile of normal human eyelid epidermis [16].
In the course of DNA replication, all dividing cells are sub-
ject to random single-nucleotide polymorphisms (SNPs). If
the mutation rate is sufficiently low that their acquisition at
a given locus in a cell subpopulation is typically associated
with a single event, they confer a potentially unique hered-
itary label on cells allowing the fate of their progeny to be
traced over time. By resolving the mutant allele fraction in
a biopsy using deep sequencing, the relative size of mutant
clones can be inferred. A similar approach based on the spon-
taneous acquisition of mitochondrial DNA mutation has been
used to address progenitor cell fate in human airways and
intestinal epithelia [17, 18]. To assess the selective growth
advantage of different mutations in normal epidermis, Mart-
incorena et al. compared the dN/dS ratio and average size of
clones derived from mutations in genes associated with cancer
drivers with those associated with synonymous mutations in
non-driver genes [16]. Their analysis showed a significant in-
crease in the abundance and average size of clones that bear
mutations in NOTCH1 and TP53 when compared with the
ensemble of apparently neutral mutations, while mutations in
other drivers such as FAT1, NOTCH2, and NOTCH3 were
not significantly increased. Based on these findings, the study
reached the striking conclusion that cancer genes are under
strong positive selection, even in physiologically normal skin.
Yet, paradoxically, despite the apparent survival advantage,
average clone sizes even in TP53 mutant clones were only a
modest factor of 2 larger that the ensemble average, suggesting
that the degree of clonal dominance may be limited.
At first sight, one might expect that the relative abundance
of gene-specific point mutations could reveal whether they con-
fer a selective survival advantage. However, while variations
in the observed frequency of SNPs will arise from the posi-
tive/negative selection of somatic mutations, they may also
be intrinsic (germline-derived) making their functional signif-
icance at different sites difficult to assess [19, 20] (Fig. S1).
Equally, the value of average mutant clone sizes is diminished
by their sensitivity to tails of the size distribution, which can
be compromised by the resolution limit of sequencing or statis-
tical fluctuations due to rare events. Similar effects may com-
promise the dN/dS ratio, a measure of the relative abundance
of non-synonymous to synonymous mutations [21]. However,
by analyzing the full probability distribution of mutant clone
sizes, and drawing upon knowledge of adult stem cell self-
renewal strategies [1, 22], we show that quantitative insights
can be gained into the dynamics and fate behavior of mutant
clones, providing access to both the normal state properties of
tissue-maintaining cells, and their dynamics following prema-
lignant transformation. In doing so, we offer a new perspective
on the deep sequencing study of Martincorena et al.
Significance
The sporadic acquistion of somatic DNA mutation confers a
hereditary label that can be used to trace the fate behavior
of cells in normal and diseased states. Applied to human tu-
mor samples, DNA deep sequencing methods have revealed the
landscape of somatic mutations and have identified a repertoire
of genes implicated in cancer. By adapting statistical methods
used to analyze lineage tracing data in transgenic animal models,
we use the example of epidermis to show how deep sequencing
data can provide quantitative insight into the self-renewal prop-
erties of normal human tissues, and can serve as a platform to
define rare non-neutral field transformations.
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Deep sequencing as a clonal marker in human epi-
dermis. In mammals, skin is composed of a multilayered
sheet of keratinocytes interspersed with hair follicles, seba-
ceous glands and sweat glands [23]. Lineage tracing studies us-
ing transgenic mouse models have revealed a surprising degree
of compartmentalization, with the turnover of hair follicle, se-
baceous gland and interfollicular epidermis (IFE) maintained
by independent stem cell populations [24]. In IFE, prolifera-
tion is confined to cells in the basal layer that adhere to an
underlying basement membrane (Fig. 1A). On commitment
to terminal differentiation, basal cells detach from the base-
ment membrane and transfer into the suprabasal layers before
reaching the epidermal surface from where they are shed. In
homeostasis, the progenitors that maintain IFE must undergo
asymmetric self-renewal so that, following division, on aver-
age one cell remains in the self-renewing compartment, while
the other commits to differentiation either directly, or via a
transit compartment with strictly limited proliferative poten-
tial. Such asymmetry may be invariant, enforced at the level
of each and every cell division, or it may be achieved only at
the level of the progenitor population (SI text).
Beginning with the work of Mackenzie and Potten, early
studies of IFE maintenance in mouse placed emphasis on a
stem/transit-amplifying cell paradigm in which long-lived slow
cycling stem cells give rise to short-lived progenitors that un-
dergo a limited series of symmetric division before terminal dif-
ferentiation [25, 26]. Later, quantitative lineage tracing stud-
ies based on inducible genetic labeling revealed that murine
epidermal maintenance relies instead upon the turnover of a
basal progenitor pool that conforms to a process of “popula-
tion asymmetry” in which their stochastic loss through ter-
minal division is perfectly compensated by the duplication of
neighbors [27, 28, 29, 30] (Fig. 1B). Whether the repair of
murine epidermis involves a transient adjustment in the fate
behavior of the progenitor pool, or is engineered by the ac-
tivity of a second quiescent “reserve” stem cell population re-
mains the subject of debate. In human, in vitro colony forming
assays, as well as transplantation and marker based studies,
point at engrained proliferative heterogeneity in the basal layer
of IFE [31, 32, 33, 34]. However, in the absence of in vivo lin-
eage tracing assays, the nature of stem cell self-renewal and
tissue maintenance remains in question.
The resolution of cell fate behavior in mouse IFE relied upon
the observation of “scaling” behavior of the clone size dis-
tribution following genetic pulse-labeling [27, 28, 29, 30, 35].
According to their stochastic fate behavior (Fig. 1B), as pro-
genitors compete neutrally for survival, the density of clones
(number per unit area) progressively diminishes, while the av-
erage size of surviving clones steadily increases (linearly with
time) so that the overall number of marked cells remains con-
stant over time (SI Text and Figs. 1C and S2). Yet, despite
their continual increase in size, the chance of finding a sur-
viving clone larger than some multiple of the average remains
constant, and defined by an exponential distribution (Fig. S2).
Combined with the overall conservation of labeled cell number,
this phenomenon of scaling provides a robust, parameter-free
signature of neutral cell competition and equipotency of the
tissue-maintaining population [35]. Although the exponen-
tial size dependence is particular to epithelial (and volumnar)
tissues, the phenomenon of scaling applies generically to all
cycling adult tissues supported by population asymmetry (SI
Text). As a result, the same general approach has been used
successfully to explore stem cell fate behavior in other tissues
and organisms [1].
In contrast to genetic labeling approaches, where the induc-
tion frequency can be controlled through the dose dependence
of the drug-inducing agent, clonal marking by somatic muta-
tion involves a sequence of sporadic events masking the age of
individual clones (Fig. 1D). Fortunately, under conditions of
neutral competition, quantitative information on the fate be-
havior of the self-renewing population can still be recovered.
In particular, if the pattern of stochastic progenitor cell fate
observed in mouse IFE (Fig. 1B) were extrapolated to human
then, following the continual “induction” of clonally marked
cells through the acquisition of somatic mutation, the prob-
ability of finding a mutant clone with n > 0 progenitors in
a biopsy of a patient of age t would be independent of the
(presumed unchanging) mutation rate and given by [17] (Figs.






where λ represents the division rate and rλ denotes the
loss/replacement rate of basal progenitors (Fig. 1B). The “fea-
tureless” 1/n divergence of the distribution at small clone sizes
is simply a manifestation of neutral dynamics that results in
the largest fraction of surviving clones at any instant being
ones that were “induced” in the recent past (cf. Fig. 1D).
If rates of somatic mutation are sufficiently high, SNPs may
arise independently at the same locus in different cells. As esti-
mates of mutant clone size using deep sequencing are based on
measurements of the variable allele fraction (VAF), the mul-
tiplicity of induction events cannot be resolved. Fortunately,
would such clone “merger” events occur, they would be sig-
naled by a breakdown of the leading 1/n dependence allowing
their existence to be inferred indirectly (SI Text). However,
while ωN/rλ 1, where N denotes the number of progenitors
in a given biopsy, and ω is the mutation rate associated with
the given locus, the frequency of mutant clones derived from
multiple induction events can be safely neglected (SI Text).
To proceed, we will assume that this condition is met and
look for consistency of the data with theory.
Although Eq. (1) provides a strong prediction with which
to address deep sequencing data, the nonlinear dependence of
Pn(t) on clone size, n, makes comparison between experiment
and theory cumbersome. Fortunately, a further straightfor-
ward manipulation of the size distribution provides a more
convenient representation. Specifically, defining the average
mutant clone size, 〈n(t)〉 ≡ ∑∞n=1 nPn(t) = rλt/ ln(rλt), it






mPm(t) ≈ e−n/rλt [2]
acquires a simple exponential dependence on clone size, n,
with a decay constant rλt, equivalent to the average size of a
surviving clone induced at birth, i.e. at the time of the first
exposure to mutation (Figs. 1E-G and SI Text). Moreover,
by the nature of its definition, the first incomplete moment is
conveniently insensitive to the smallest clones, where the reso-
lution of the deep sequencing approach is likely to be compro-
mised. In the context of epidermis, it therefore follows that
the corresponding distribution of clone areas, A, is given by
µ1(A, t) = e
−ρA/rλt, with ρ the areal progenitor density.
Eq. (2) provides an objective, parameter-free prediction
with which population asymmetry and neutrality of clone dy-
namics can be assessed. For a given array of biopsies, mu-
tant clone sizes can be inferred from the corresponding VAFs
associated with individual SNPs. Then the first incomplete
moment, µ1(A, t), can be constructed directly from the data.
Departure of the inferred distribution from the predicted ex-
ponential size dependence would indicate functional hetero-
geneity of mutant clones and evidence of non-neutral dynam-
ics. Convergence onto exponential would indicate that clone
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dynamics is likely governed by the neutral competition of an
equipotent progenitor pool. A fit to the exponent, rλt/ρ, then
provides access to the progenitor loss/replacement rate. Cru-
cially, the exponential size dependence of µ1(A, t) is sensitive
only to the dynamics of the self-renewing (i.e. the active stem
cell) population. As long as the dominant contribution to the
measured mutant clone size distribution derives from clones
associated with mutations that occurred on timescales in ex-
cess of the transit time through any differentiation hierarchy,
the exponential size dependence would be conserved.
Neutral competition between keratinocyte progeni-
tors. In the study of Martincorena et al. [16], eyelid epider-
mis was derived from more than 200 biopsies of sizes ranging
from 0.79 to 4.71 mm2 harvested from 4 patients aged 55 to
73 years of age. In each case, coding exons were sequenced
across 74 genes implicated in skin and other cancers to an
average effective coverage of 500× (SI Data). (For technical
details on the sample preparation and sequencing approach,
we refer to Ref. [16].) As detailed in the study, since few
mutations involve change in copy number, the areal contri-
bution of individual mutant clones can be inferred as twice
the product of the VAF with the area of the biopsy. (Events
involving the mutation of both alleles at a given locus are con-
sidered to occur at a negligible frequency.) For clones of a size
much smaller than that of the biopsy, intersection of the clone
with the boundary is statistically improbable. For larger clone
sizes, the estimated clonal area in a given biopsy may repre-
sent only a fraction of the true size. However, the exponential
character of the predicted first complete moment is robust to
such statistical fluctuations as well as errors in the accuracy
of the sequencing approach (SI Text).
To gain insight into the relative abundance of clones that
“spill” outside individual biopsies, since the mutation rate is
low [16], we can explore the coincidence of common point mu-
tations found in different biopsies. Taking as an exemplar
patient PD18003, for which the largest volume of data was
obtained, we find that, from 1557 specific point mutations
across 92 biopsies, some 102 (6.6%) are present in more than
one biopsy. Of these, 90 point mutations are restricted to two
biopsies, 10 span 3, 1 spans 4, and 1 spans 5. Similar frequen-
cies of clone dispersion are found for the three other patients
(Table 1), with one clone spanning no less than 12 biopsies.
Since the total area of clones that occupy multiple biopsies
cannot be reliably recovered, we first focused on the ensem-
ble of clones that bear a point mutation contained within a
single biopsy. Further, to assess the utility of the approach,
we began by focusing on the subset of these clones that in-
volve only synonymous mutation (Figs. 2A and S3). As such
mutations leave the associated protein sequence unchanged,
it is expected that the dynamics of the corresponding clones
remains neutral, providing a useful control to benchmark the-
ory. Focusing on patient PD18003, for which there were a
total of 257 synonymous point mutations restricted to a sin-
gle biopsy, analysis of the first incomplete moment, µ1(A, t),
reveals a remarkably exponential size dependence (Fig. 2B),
consistent with neutral competition of the constituent progen-
itors. As well as justifying the validity of the approach, this
result establishes that, under conditions of normal homeosta-
sis, the progenitors that maintain adult human IFE conform
long-term to population asymmetric self-renewal.
With the size distribution of clones associated with syn-
onymous mutations defined, we then considered the wider
class of mutant clones including both synonymous and non-
synonymous (missense and nonsense) mutations. Once again,
taking the 1338 clones associated with a single point mutation,
the size distribution, µ1(A, t), shows only a small departure
from exponential with the divergence impacting at the largest
clone sizes (Fig. 2C, arrow head). By fitting the data to the
exponential clone size dependence (red curve), we can then
use the predicted cumulative frequency to estimate the point
of departure of the statistical distribution. Given the size of
the ensemble of clones, we find that the observation of the 7
largest clones with a size in excess of 1.08 mm2, a significant
fraction of the size of the associated biopsies, would be statis-
tically improbable within the framework of neutral dynamics,
i.e. these clones would be predicted to occur with a frequency
much less than 1 in 1000. Furthermore, inspection of the muta-
tional profile of the 6 biopsies containing the 7 clones (Fig. S4)
shows that 5 biopsies are associated with different point muta-
tions (missense or frameshift deletion) in NOTCH1, while the
sixth involves a missense mutation in MLL2. For the latter,
3 other mutations appear with a very similar VAF to MLL2
(Fig. 2D), suggesting that all four mutations belong to the
same clone. Significantly, when these 6 biopsies are filtered
out of the statistical cohort of 92, the first incomplete mo-
ment collapses onto a strikingly exponential size dependence
(Figs. 2E,F). The coincidence of theory and experiment is fur-
ther emphasized by comparison of the clone size distribution,
P (A, t), with the predicted size dependence (Fig. 2G).
Turning to patient PD13634, of the 725 discrete point mu-
tations, 657 (89%) belong to a single biopsy with 159 of these
associated with synonymous point mutations. Once again,
their size distribution shows collapse onto an exponential de-
pendence, consistent with neutral dynamics (Fig. S5A). Then,
when combined with non-synonymous mutations, the size dis-
tribution of all 657 mutant clones continues to collapse onto
exponential with no apparent outliers by size (Figs. S2 and
S5B). For patient PD20399, of the 803 discrete point muta-
tions, 724 (90%) belong to a single biopsy. In this case, the
size distribution of all 724 point mutations as well as the 154
mutant clones that bear a synonymous mutation also collapse
onto exponential with no outliers by size (Figs. S2, S5C and
S5D). Finally, for patient PD21910, although the data is rel-
atively sparse, of the 195 discrete mutations, 181 (93%) be-
long to a single biopsy. With just 35 of these mutant clones
bearing a synonymous point mutation, the size distribution
is noisy but consistent with exponential (Fig. S5E). Again,
as expected, comparison of all 181 mutations also reveals a
collapse onto exponential with no outliers (Figs. S2 and S5F).
Non-neutral expansion of rare mutant clones. Although
these results suggest that the vast majority of point mutations
leave neutral dynamics unperturbed, the statistical method
also provides a quantitative scheme to identify mutant clones
that lie outside the normal (exponential) size distribution.
Our results suggest that very few are associated with non-
neutral dynamics - in one patient (PD18003), just 6 outlier
clones were identified by size, while none were found in the
other patients (Figs. 2 and S5). However, so far, we have
excluded from our analysis mutant clones that span multiple
biopsies. Since these clones are likely to be large, one might
expect that they harbor the majority of cells that have under-
gone non-neutral transformation. Therefore, to gain insight
into the nature of these dispersive clones, we explored the mu-
tational profile of clones that spanned more than 3 biopsies.
Starting with patient PD18003, only one mutant clone bear-
ing a missense mutation in SCN1A (C927S) spans more than
3 biopsies (Table 1), having an aggregate size of 2.52 mm2,
more than a factor of two larger than the cut-off used to fil-
ter single-biopsy clones. Whether this outlier represents the
chance expansion of a clone governed by neutral dynamics,
or derives from the proliferative advantage of mutant cells
Footline Author PNAS Issue Date Volume Issue Number 3
i
i






over their wildtype neighbors – the process of “field cancer-
ization” [36] – driven by mutation of SCN1A is impossible to
determine unambiguously. However, noting that the vast ma-
jority of the clone is limited to just one biopsy in which the
point mutation in SCN1A is expressed with a VAF similar to
that of point mutations associated with 3 other genes (Figs.
3A,B), it seems likely that expansion of this clone is driven by
the chance acquisition of multiple point mutations. Indeed,
by comparing the relative values of the VAFs, we can infer
the likely order in which these point mutations were acquired
(Fig. 3C).
Similarly, in patient PD20399, a clone bearing a missense
point mutation in FGFR3 (R248C) spans no less than 12 biop-
sies covering an aggregate area of 7.41 mm2. However, as noted
by Martincorena et al. [16], in six of the 12 biopsies, this mu-
tation appears alongside two other missense point mutations,
one in TP53 (P250L) and one in ARID1A (P929S), with all
three bearing a very similar VAF (Fig. 3D). This coincidence
suggests that it is the acquisition of these secondary mutations
that drives non-neutral expansion of the clone. From the rela-
tive sizes of the three constituent mutations, we can infer the
likely sequence of their acquisition (Fig. 3E). Interestingly,
the large dispersion of the clone bearing the original mutation
in FGFR3 and its irregular spatial pattern (Fig. 3D) suggests
that, either mutation in FGFR3 occurred independently at
the same locus, or this mutation may have a developmental
origin. A second clone mutant for NOTCH2 (P426S) spans 5
biopsies, but the majority lies within just two. In this case,
its net aggregate size of 0.75 mm2 suggests that it may belong
to the ensemble of neutral mutations.
For patient PD13634, inspection of the mutational profile
shows that one point mutation spans 7 biopsies, 3 span 5, and
4 span 4. Inspection of the mutational profile shows these
events can be traced to the expansion of just two clones and
their subclones. Comparison of the VAFs of the constituent
mutant clones suggests that, in one case, a consecutive se-
quence of 5 independent point mutations starting with FGFR3
(*809G), followed by PPP1R3A (P967L), ARID1A (G851D),
NOTCH1 (P574S) and NOTCH1 (P745), drives non-neutral
expansion leading to a clone with an aggregate size in excess
of 8 mm2 (Fig. 3F). A second independent clone, involving
a synonymous mutation in MUC17 (T3292T) followed by a
nonsense mutation in SPHKAP (W308*), leads to a much
smaller clone with an aggregate size of only 0.77 mm2, well
within the statistical ensemble of neutral mutations. Finally,
for patient PD21910, there are no mutations that extend be-
yond two biopsies.
For consistency, we can further filter the ensemble of biopsies
excluding those that contain the two oversized clones in pa-
tients PD13634 and PD20399. Since these clones are subject
to non-neutral expansion, they may impact upon neighbors
by either suppressing their expansion, or conveying them as
passengers. Once removed, we find that the first incomplete
moment maintains its exponential character, while the total
clone size distribution falls onto the predicted size dependence
(Fig. S6). Finally, to further challenge the hypothesis of neu-
trality, we determined the average mutant clone size across a
range of genes. For all 4 patients, we found that departures of
the average clone size associated with specific cancer drivers
from that of the ensemble were not statistically significant
(Fig. S7).
Although these findings suggest that the majority of mu-
tations leave neutral dynamics unperturbed, it is important
to consider what would emerge if the dynamics were non-
neutral. If all point mutations conferred the same prolifer-
ative advantage, the first incomplete moment would also ac-
quire an exponential size dependence, µ1(n, t) ≈ e−n/N(t),
with N(t) = eνt and ν defining the net proliferative expansion
rate of mutant progenitors [37]. However, since such a size
dependence would require all point mutations (synonymous
and non-synonymous) to confer precisely the same prolifera-
tive advantage, its relevance to the current study is unlikely.
It is, however, important to note that, while the statistical
approach provides the means to define clones that lie outside
the normal size distribution, we cannot rule out the existence
of a further subfraction of clones associated with non-neutral
transformation that lie hidden within the bulk of the neutral
distribution.
Discussion. These results demonstrate how analysis of
deep sequencing data provides a general framework to study
stem cell self-renewal of normal cycling adult human tissues.
Applied to human IFE, we find that maintenance involves
the turnover of a progenitor population following population
asymmetry in which their stochastic loss through differentia-
tion is compensated by duplication of neighbors. From a fit
of the data to the exponential size dependence of µ1(A, t), the
inferred ratios rλt/ρ are found to broadly consistent with the
predicted linear increase with the age of the patient (Table
2). With an estimated basal cell density of ρ = 10, 000 cells
per mm2 [38], and a progenitor fraction of basal cells of 1 in
3 (extrapolated from mouse [27]), a linear fit of the measured
ratio suggests a loss/replacement rate of the self-renewing pop-
ulation of rλ ≈ 0.5 per week. Although uncertainty in both
the progenitor fraction and the relative frequency of divisions
leading to symmetric or asymmetric fate undermine the pre-
dictive value of this rate, a loss/replacement time measured
in weeks is broadly consistent with the expected proliferative
activity of cycling keratinocyte progenitors in normal home-
ostasis which, on the basis of BrdU incorporation, points at an
average cell division rate in human scalp epidermis of around
2 per week [38].
Significantly, the deep sequencing approach also provides a
quantitative assay to expose rare mutant clones that have un-
dergone field transformation and to assess their mutational
profile. Application of this approach to human epidermis
shows that, despite evidence for positive selection [16], popu-
lation asymmetry and neutrality of epidermal progenitor cell
fate may be surprisingly robust to the acquisition of somatic
point mutations, even in genes associated with cancer drivers.
Indeed, the multiplicity of mutations in the minority of clones
(ca. 0.1% or less) that lie outside the normal size distribu-
tion suggests that proliferative advantage may typically rely
on epistasis, requiring the acquisition of multiple mutations
across a range of genes.
Under conditions of normal homeostasis, clonal evolution
in IFE is constrained to two dimensions, with clones expand-
ing in cohesive clusters across the basal and suprabasal lay-
ers (Fig. 1C). Applied to higher dimensional (volumnar) tis-
sues, as well as other epithelial tissues, the same clone size
dependence is predicted to apply without further revision (SI
Text) [35]. However, if occupancy of the self-renewing com-
partment is constrained to lower dimension, or if stem cells are
restricted to closed niche domains, the same general technol-
ogy applies, but the predicted mutant clone size distribution
must be appropriately revised (SI Text). Therefore, applied to
deep sequencing studies, the current theoretical scheme pro-
vides a general method to probe stem cell fate behavior in
normal cycling adult human tissues, and to identify the exis-
tence and mutational signature of rare field transformations
driven by the non-neutral dynamics of mutant cells, with po-
tential applications to the early detection of preneoplasia.
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Fig. 1. Dynamics of clones in mammalian IFE. (A) Schematic depicting the cellular organization of human IFE. (B) In the paradigm of population asymmetry, IFE
is maintained by basal progenitors that, following division, choose stochastically between symmetric and asymmetric fate with the probability of symmetric proliferation,
0 < r ≤ 1/2, perfectly balanced by terminal division. (C) When lineage labeled, the clonal progeny of marked progenitors may expand through the replacement of neighbors
(yellow clone), or may become lost through differentiation (green clone). (D) Following the chance acquisition of somatic mutation, clones (with colors denoting different
SNPs) compete for survival. Over time, some clones become lost through differentiation while others expand. Clones that bear one mutation may acquire further mutations.
(E) According to the model depicted in B, the average size of mutant clones (orange line) is predicted to increase as ωNt, where ω denotes the mutation rate per progenitor
at a given locus, N is the size of the progenitor pool, and t is the age of the patient. The average mutant clone size is predicted to increase as rλt/ ln(rλt) (black line). (F)
The corresponding mutant clone size distribution, Pn(t), and (G) first incomplete moment, µ1(n, t) predicted by Eqs. (1) and (2) respectively (black lines). In E-G points
show the results of stochastic simulation of the birth-death process B where, in F and G, λt = 26 (orange), 28 (brown), 210 (grey), and 212 (black) with ωN/λ = 1 and
r = 1/2.
Fig. 2. Size distribution of mutant clones provides evidence of neutral dynamics. (A) Mutant clone sizes inferred from the analysis of the variable allele fractions of all
(N=1557) point mutations for patient PD18003 (black points). Synonymous mutations are marked as red, and mutations belonging to the 6 biopsies considered outliers by
size are shown as brown. (B) First incomplete moment, µ1(A, t), associated with N=257 synonymous mutations that belong to single biopsies (points) shows collapse onto
the predicted exponential size dependence (Eq. (2), red line and Table 2). (C) First incomplete moment associated with all (N=1338) point mutations that belong to single
biopsies. The departure of µ1(A, t) (arrow head) from exponential (red line) reflects contributions from 7 mutant clones contained within 6 biopsies. (D) Clone sizes of
one biopsy showing one of the outliers associated with mutation in MLL2 (**). Note that three other point mutations have clone sizes comparable to this outlier suggesting
that they belong to the same subclone. Non-point mutations are indicated as grey. When the 6 biopsies are excluded from the statistical ensemble, the distribution µ1(A, t)
(points) shown in (E,F), collapses onto the predicted exponential form (red line and Table 2). (G) The corresponding clone size distribution, P (A, t), with points (black)
showing data and the line (red) showing the theoretical prediction of Eq. (1). The departure of theory from experiment at clone sizes below of 0.05mm2 and below indicates
the resolution limit of the sequencing approach. With a basal cell density of 10,000 cells per mm2, this suggests that a resolution limit of around 500 basal cells. Error bars
denote s.e.m.
Fig. 3. Field transformation and non-neutral clone dynamics driven by multiple mutations.
(A) Coordinates of biopsies of eyelid epidermis sampled for patient PD18003 with the size
of points scaled by biopsy area. Colored points contained within single biopsies depict the 6
biopsies containing the 7 mutant clones considered outliers by size. Green points mark 5 biopsies
sharing the same point mutation in SCN1A. Size of colored dots scaled by the size of the outlier
clones or the shared mutant clone. (B) Size of mutant clones belonging to one of the 5 biopsies
with SCN1A mutation. Comparison of VAFs across all 5 biopsies suggest the clonal structure
depicted in (C). (D) Coordinates of biopsies from patient PD20399 with the size of dots scaled
by the area of the biopsy. The 12 biopsies colored light or dark green share the same point
mutation in FGFR3 while the 6 biopsies marked in dark green also share point mutations in
TP53 and ARID1A. Green biopsies scaled by the size of the majority mutant clone. (E) Clonal
organization implied by the mutational landscape of the clone depicted in D. (F) Analysis of
mutational profile of mutant clones that span more than 3 biopsies in patient PD13634 reveal
an oversized clone with the given clonal architecture.
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Table 1. Frequency of point mutations shared by
multiple biopsies.
Number of biopsiesPatient ID
1 2 3 4 5 6 7 12
PD13634 647 63 7 4 3 1
PD18003 1338 90 10 1 1
PD20399 724 64 10 1 3 1
PD21910 181 14
Multiplicity of point mutations that span multiple biopsies. For exam-
ple, in patient PD13634, 647 point mutations are found in only one
biopsy, 63 and found in 2 biopsies, etc.
Footline Author PNAS Issue Date Volume Issue Number 1
Table 2. Fit of the rst incomplete moment to the predicted
exponential size dependence.
Patient
PD18003 PD13634 PD20399 PD21910
Age/years (sex) 65 (F) 73 (M) 55 (F) 58 (F)
rt= (mm2R2) (syn.) 0:200:98 0:220:98 0:120:96 0:310:87
rt= (mm2R2) (all) 0:250:99 0:240:94 0:140:98 0:320:96
r= (mm2 yr 1) 0:0039 0:0032 0:0025 0:0054
Ratios rt= inferred from ts to 1(n; t) (red lines in Figs. 2 and S5E and S6)
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The quantitative analysis of the probability distribution of mutant clone sizes described in the
main text relies upon a robust and generic model of stem cell self-renewal in adult cycling
tissues. In the following, we expand upon the theoretical basis of the modeling scheme,
and the derivation of the size distribution of mutant clones defined by Eq. (1) in the main
text. Furthermore, we discuss generalizations of the theoretical scheme to different tissue
architectures.
Background: As a starting point, it is necessary to review the constraints that restrict the
possible fate behavior of progenitors that maintain cycling adult tissues. For clarity, we refer
to this cycling and self-renewing population as progenitors rather than stem cells noting
that, in the context of epidermis as well as other tissues, these cells may be underpinned by a
second quiescent “stem cell” population. To achieve long-term homeostasis, the maintenance
of a cycling tissue must ultimately rely on the turnover of a single equipotent progenitor pool1
that divides asymmetrically so that, on average, one daughter cell stays in the self-renewing
compartment while the other commits to differentiation, either directly or through a transit
compartment with a strictly limited proliferative potential [35].
Although fate asymmetry may be invariant, enforced at the level of individual cell divi-
sions, it may also follow from a stochastic pattern of behavior in which chance progenitor
cell loss through differentiation is perfectly compensated by the duplication of neighboring
cells (cf. Fig. 1B). In this mode of “population asymmetric” self-renewal, neutral competi-
tion between progenitors leads to a gradual consolidation of clonal diversity, while the size
of surviving clones continually increases (cf. Figs. 1C and S2).
On this background, consider the impact of a neutral hereditary label (such as a synony-
1Note that the equipotency of progenitor cell behavior over long times does not rule out potential short-term
heterogeneity in which progenitors transfer reversibly between states biased for duplication or differentiation
[22]
1
mous point mutation) that marks a progenitor cell. In systems characterized by invariant
asymmetric self-renewal, individual progenitor cells are long-lived and, once acquired, a
marked cell would persist indefinitely. By contrast, in systems defined by population asym-
metric self-renewal, through neutral competition between neighboring progenitors, a marked
cell and its progeny - a clone - may, by chance, be purged from the population, or the clone
may expand (cf. Fig. 1C). In a tissue defined by an ensemble of closed niche domains,
such as the crypt organization of the intestinal epithelium, this process of “neutral drift” and
clonal consolidation continues until the clone is lost, or cells in the given niche domain drift
to monoclonality and the hereditary label (mutation) becomes locally fixed. By contrast,
in systems defined by an open or facultative niche, such as the interfollicular epidermis or
testis, the neutral dynamics of clones would continue unabated.
To address the quantitative dynamics of clones in an open or “facultative” niche sub-
ject to population asymmetric self-renewal, it is important to discriminate between different
patterns of regulation [35]. If the balance between proliferation and differentiation follows
from intrinsic (cell autonomous) regulation, long-term clone dynamics of the progenitor pool




P + P Pr. 1/2
∅ Pr. 1/2 .
where rλ denotes the effective loss/replacement rate of progenitors P . Here, we have chosen
our definition of the loss/replacement rate to align with the particular model of progenitor
cell self-renewal in IFE, as depicted in Fig. 1B. Furthermore, we have suppressed progenitor
cell divisions that lead to asymmetric fate outcome as these leave the progenitor cell number
- and therefore the progenitor clone size - unchanged.
Then, if we start with a progenitor population of total sizeN  rλt, the chance of finding












In particular, at times rλt  1, the distribution of “surviving” clones, i.e. those contain-
ing at least one progenitor, converges onto a hallmark exponential clone size distribution,
pn(t)/(1 − p0(t)) = (1/rλt) exp[−n/rλt]. From this result, it follows that the cumulative
distribution, defined as the chance of finding a surviving clone with a size greater than n
2
progenitors, is given by exp[−n/〈n(t)〉], where 〈n(t)〉 ' rλt defines the average size of sur-
viving clones, i.e. while the average size of surviving clones increases, the chance of finding
a clone with a size given by some mulitple of the average remains constant over time, and
defined by an exponential distribution. The speed with which the size distribution conver-
gences to this “scaling” limit is illustrated by the results of a stochastic simulation shown in
Fig. S2.
Conversely, if the balance between proliferation and differentiation follows from extrin-
sic regulation (such as neutral competition for limited niche access), the long-term clonal
dynamics depends on the local coordination of neighboring progenitor cells, and therefore
the effective “dimensionality” of the niche [35]. In dimensions of two (epithelial) and above
(volumnar), the clone size distribution converges onto the same exponential size dependence
as that defined above for intrinsic regulation. However, in quasi one-dimensional (ductal)


















where λ defines the loss/replacement rate of neighboring progenitors. In this case, the sur-
viving clone size distribution takes the form pn(t)/(1 − p0(t)) = (n/2λt) exp[−n2/4λt].
Once again, the chance of finding a clone with a size larger than n progenitors is given by
the scaling form, exp[−(pi/4)(n/〈n(t)〉)2], where 〈n(t)〉 ' √piλt defines the average size of
surviving clones.
Mutant clone dynamics in interfollicular epidermis
With these preliminaries, let us now consider mutant clone dynamics following the acqui-
sition of a neutral somatic point mutation in the IFE. In particular, let us suppose that cells
belonging to the self-renewing progenitor pool acquire sporadic point mutations at a low
rate of ω per base per progenitor cell, where ω may vary substantially with the specific locus
along the genome. Later we will define what we mean by a “low mutation rate”. Each point
mutation then serves as a hereditary clonal marker identifying mutant cells and their progeny.
In the course of turnover, through (neutral) competition with neighbors, the clonal progeny
of these mutated cells may survive and expand or they may become extinct. Formally, in
this case, the dynamics is equivalent to a critical birth-death process with immigration [39].
If each progenitor cell simply persisted without loss and replacement, i.e. rλ = 0, then for
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ωt  1, where t denotes the time during which the population is exposed to mutations (i.e.
the age of patient), the multiplicity of marked (mutated) cells, M , at any given locus would
be given by a Poisson distribution,
ZM(t) =
N !
(N −M)!M ! (ωt)




Over time, the field of cells without mutation at this locus must steadily decrease, leading to
a small adjustment of this probability. However, providing the fraction of mutated cells at
a given locus remains small, M/N  1, the adjustment of ZM(t) can be safely neglected.
In this case, the average number of cells with a mutation at the given locus is given by
〈M〉 = ωNt.
With this definition, we may now construct the size distribution of mutant cells at a given
locus in the population. More precisely, the chance, Qn(t), of finding n mutant progenitor
















δn,n1+···nM pn1(t1) · · · pnM (tM).
Formally, the first component describes the multiplicity of mutated cells. Each of these
mutations could have occurred at any time between 0 and t. Each will produce a clone with
n progenitor cells with probability pn(t) integrated over time t. Summing the total number
of marked cells, n, for each induction event gives the total number of progenitor cells with a
mutation at that locus in the genome.
Then, if we suppose that the balance between proliferation and differentiation follows






· · ·nM −n)], all time integrals and cell number summations can be performed. In particular,
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1− e−iφ)]−ζ , (1)
where we have defined the parameter ζ = ωN/rλ which indexes the relative frequency
of mutations to progenitor cell loss/replacement events. In the particular case that n = 0
(i.e. when no cells bear a mutation at a given locus), the integral over φ can be performed
explicitly and leads to the probability, Q0(t) = (1 + rλt)−ζ . For n > 0, the integral cannot
be performed exactly, but does admit to useful limits. Specifically, when the mutation rate is
low as compared to the loss/replacement rate, ζ  1, the integrand can be expanded and the
full distribution converges to the form,




Note that, in this limit, the frequency of cells that have escaped mutation at a given locus
declines only logarithmically with time. This slow (logarithmic) dependence reflects the fact
that the majority of cells that acquire a mutation at a specific locus will most likely become
lost through neutral competition with non-mutated neighbors.
From this result, we find that the size distribution of surviving mutant clones, Pn(t) =







is independent of (and therefore insensitive to genomic variations in) the mutation rate, ω.
This result (Eq. (1) of the main text) is easy to understand: In the limit ζ  1, there is
typically at most only one clone that contributes to the frequency of mutations at the given
locus. In this case, the distribution should converge to the time-integrated form of pn(t),
5
which gives rise to the e−n/rλt/n dependence.
More generally, when the rate of mutation is larger, individual point mutations may not
confer a unique clonal label. Instead, contributions from independent clones associated with
mutations at the same locus will contribute to a net variable allele fraction. Qualitatively,
such contributions are evidenced by the acquisition of a peak in the mutant clone size distri-
bution. To determine an estimate for Qn(t), we can make use of a stationary phase approxi-
mation to evaluate the integral in Eq. (1). Varying the exponent of the integrand with respect
to φ, we obtain the stationary phase solution,






Then, taking rλt 1, n ζ & 1, and making use of the approximation,










Then, expanding the integrand in fluctuations η = φ− φ¯, and integrating, we obtain























Finally, using this result to construct the surviving clone size distribution, and normalizing,










where Γ[ζ] denotes the Gamma function.
Although Eqs. (2) and (3) provide a prediction with which to address deep sequencing
data, the non-trivial dependence of the size distribution Pn(t) on nmakes a direct comparison
with theory cumbersome. Fortunately, the size distribution is easily manipulated into a form
where it translates to a simple exponential dependence. In particular, for ζ  1, if we
define the average mutant clone size 〈n(t)〉 = rλt/ ln(rλt), the first incomplete moment (cf.
Ref. [37])





acquires an exponential dependence on clone size n (Eq. (2) of the main text). In this
form, the clone size dependence may be straightforwardly compared with experimental data.








the generalized incomplete moment,




also acquires a simply exponential form. Operationally, when the ratio of the mutation and
loss/replacement rate, ζ , is unknown - which would typically be the case - it would be neces-
sary to continuously adjust ζ until the incomplete moment µ1−ζ(n, t) acquires an exponential
form.
Resolution limit of deep sequencing
The practical implementation of this analytical scheme relies on the ability to faithfully re-
construct the mutant clone size distribution from measurements of the variable allele fraction
using deep sequencing. In practice, the reliability of this approach will be comprised by sev-
eral factors, some of which have been addressed in the main text. However, one significant
effect which we must consider is the impact of the resolution limit of the sequencing ap-
proach which will typically place a lower limit on the size of the smallest clones that can be
resolved. However, if we adjust the size distribution to accommodate a cut-off, n0, excluding
mutant clones of size n ≤ n0  rλt, the generalized incomplete moment takes the form
µ1−ζ(n, t) = e−(n−n0)/rλt,
for all ζ including ζ → 0. Therefore, it follows that the potential limitation of the deep
sequencing approach in capturing the smallest clones does not change the exponential char-
acter of the size dependence of the generalized incomplete moment. Instead, it imposes
an overall constant prefactor. Therefore, while the exponential character of the generalized
incomplete moment can be assessed directly, a fit to the experimental data requires the ad-
justment of both rλt and the unknown size cut-off n0. It is this procedure that we use to fit
the data sets in Figs. 2, S5 and S6.
7
Alongside the resolution limit, the estimate of clone sizes from the measured variable
allele fractions are subject to additional sources of error and uncertainty. First, clones may
extend outside the boundaries of individual biopsies, leading to an underestimate of mutant
clone size. Second, errors due to variations in the read depth of the sequencing will also com-
promise the accuracy of the method. Fortunately, the exponential character of the predicted
clone size distribution serves to mitigate against the impact of such errors. In particular,
suppose that the sequencing approach leads to a sampling error that translates to a normal






where σ denotes the standard deviation of the error. In this case, the first incomplete moment































Therefore, providing σ  √n rλt, the correction of the first incomplete moment due to
fluctuations will be small. For the smallest clone sizes n, this condition cannot be met.
However, such contributions are in any case below the resolution limit of the sequencing
approach. Conversely, for n = O(rλt), consistent with the typical clone sizes examined
here, this condition will be safely met.
Generalizations of the analytical approach
Until now, we have focussed our analysis on the dynamics of cycling adult tissues in which
the self-renewing progenitor cell population conforms to a pattern of population asymmetry
in which stochastic fate behavior follows from intrinsic (cell-autonomous) regulation. As
discussed above, for systems in which population asymmetric follows from extrinsic regula-
tion (e.g. when stem cells compete neutrally for limited niche access), in dimensions of two
(epithelia) and higher (volumar), the mutant clone size distribution (and the corresponding
incomplete moments) are predicted to assume the same functional dependence, i.e. as with
a pulse-labeling clonal assay, in dimensions of two and above, the mechanism of regula-
8
tion (intrinsic vs. extrinsic) cannot be inferred from the analysis of the mutant clone size
distribution alone.
However, as emphasized above, if cell dynamics follows from extrinsic regulation, in
the one-dimensional or quasi one-dimensional geometry (viz. ductal or tubular tissues), the
mutant clone size distribution must be revised. In particular, when the mutation rate, ω, is low

























2 denotes the complementary error function. In this case,
the frequency of non-mutated clones diminishes more rapidly, as the clonal loss rate due to
neutral competition scales only as 1/
√
t. As a result, the size distribution of surviving mutant







































Then, with the average clone size given by 〈n(t)〉 = ∑∞n=1 nPn(t) ' √piλt2 , the first



















































Finally, if tissues are divided into an ensemble of isolated niche domains, such as the
9
glandular crypt structures found in the intestinal tract and stomach, the mutant clone size
distribution must be revised again. In this case, the chance induction of stem cells through
somatic mutation may, through neutral competition, lead to the clonal fixation of individual
glands in which all constituent cells become monoclonal. With NS defining the (effective)
stem cell number per gland, we expect the frequency of monoclonal glands associated with
a specific mutation to grow as ωNgt, where Ng denotes the total number of glands in the
biopsy sample, and ω denotes the locus-specific mutation rate per stem cell. Alongside
this growing fraction of monoclonal glands, at any given instant in time, we expect to find
a time-independent distribution of partially mutated glands corresponding to clones whose
fate (extinction through neutral competition or fixation) has yet to resolve. In the quasi one-
dimensional arrangement of stem cells in the intestinal crypt of the colon or small intestine,
the size distribution of these partially labeled crypts is given simply by
PNS>n≥1(t) =
2(NS − n)
NS(NS − 1) ,
independent of time, t.
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Supplementary Figure S1. Abundance of gene-specific mutant clones.
(A) Scatter plot of the exome length in the genome against the total number of mutant clones
associated with that exome (coverage obtained from AceView, NBI). The points show all
genes considered in the deep sequencing study of Martincorena et al. In particular, we
have picked out the abundance of specific genes that emerge as outliers from the otherwise
neutral size distribution of mutant clones, as discussed in the main text. The results reveal no
obvious correlation of exome length with clone number, emphasizing the degree of intrinsic
variation of the mutation rate along the genome. (B, left) In common with previous studies
of translated exons [40], the distribution of sequenced exon lengths (bars) is consistent with
a log-normal distribution, exp[−(Log2(Length)−Log2a)2/2σ] centered on a = 27.0 bp with
a width σ = 2.9 (red line). (B, right) Although there is no obvious correlation between exon
length and mutant clone abundance, the corresponding distribution of mutant clone number
for the chosen exons is also broadly consistent with a log-normal distribution centerd on
a = 25.2 bp with the same width, σ.
Supplementary Figure S2. Neutral dynamics and scaling of the clone size distribution.
(A) According to the paradigm of balanced stochastic fate choice (Fig. 1B), following pulse-
labeling, the average clone size (progenitor number) is predicted to increase as 1 + rλt
(black line, SI Text), while the clone survival probability falls as 1/(1 + rλt) (orange line),
so that the overall average number of labeled progenitors per clone (brown line) remains
constant at unity. (B) The corresponding cumulative clone size distribution converges onto
an exponential dependence, a manifestation of scaling behavior (black line, SI Text). Points
in A and B represent the results of stochastic simulation of the corresponding critical birth-
death process, with chase times in B of λt = 26 (orange), 28 (brown), 210 (grey), and 212
with r = 1/2 (black).
Supplementary Figure S3. Distribution of mutant clone sizes.
Sizes of the N = 1557, 725, 803 and 195 clones associated with (synonymous and non-
synonymous) point mutations that are contained within single biopsies for, respectively, pa-
tient PD18003, PD13634, PD20399 and PD21910 before filtering.
Supplementary Figure S4. Mutational profile of biopsies containing outlier clones in
patient PD18003.
Mutational profile of the 7 mutant clones (denoted by **) in patient PD18003 considered
as outliers by size and contained within 6 biopsies with the specific mutant genes marked
11
in red. Large mutant clones with similar sizes (also marked in red) are likely to represent
subclones of the outlier mutant clone. Non-point mutations are marked in grey.
Supplementary Figure S5. Neutral progenitor cell dynamics is conserved across pa-
tients.
First incomplete moment, µ1(n, t), associated with N = 159, 154 and 25 synonymous mu-
tations that belong to single biopsies (points) of, respectively, patient (A) PD13634, (C)
PD20399 and (E) PD21910 show collapse onto the predicted exponential size dependence
(Eq. (2), red line and Table 2). First incomplete moment associated with all N = 647, 724
and 181 point mutations that belong to single biopsies (points) of, respectively, patient (B)
PD13634, (D) PD20399 and (F) PD21910 also show collapse onto the predicted exponential
size dependence (Eq. (2), red line and Table 2). Error bars denote s.e.m.
Supplementary Figure S6. Filtered clone size distribution confirms neutral clone dy-
namics.
(A-C) and (D-F) show the first incomplete moment, µ1(n, t), and clone size distribution,
Pn(t), for patients PD13634 and PD20399, respectively, following the removal of biopsies
containing the two clones that span multiple biopsies depicted in Fig. 3. Points show data
and the lines show a fit to the predicted distributions Eqs. (1) and (2). Error bars denote
s.e.m.
Supplementary Figure S7. Average clone size for typical driver genes is consistent with
neutral dynamics.
Average size of mutant clones belonging to different cancer drivers (black) compared by the
ensemble average of all genes (red) for patient (A) PD18003, (B) PD13634, (C) PD20399
and (D) PD21910. Note that, for the majority of genes and patients, the departure of the
average clone size for cancer drivers from the ensemble average is not statistically signifi-
cant. Error bars denote s.e.m. To test for inequivalence of specific genes from the ensemble
average, we have used a Kolmogorov-Smirnov test to compare mutant clone size distribu-
tions. The p-values from the four patients, PD18003, PD13634, PD20399 and PD21910
are, respectively, given by NOTCH1: 0.050, 0.18, 0.025 and 0.25; NOTCH2: 0.081, 0.31,
0.97 and 0.25; NOTCH3: 0.34, 0.15, 0.66 and 0.19; NOTCH4: 0.43, 0.14, 0.99 and N/A;
FGFR3: 0.16, 0.54, 0.012 and N/A; ARID1A: 0.51, 0.81, 0.043 and 0.92; PPP1R3A: 1.00,
0.17, 0.27 and 0.072; TP53: 0.53, 0.06, 0.33 and 0.37; FAT1: 0.46, 0.96, 0.92 and 0.044;
GRM3: 0.95, 0.18, 0.64 and 0.92; SCN1A: 0.51, 0.65, 0.078 and N/A; FBXW7: 0.84, N/A,
12
0.65 and N/A. These results show that, for all but three entries, the statistical equivalence of
the distributions cannot be ruled out (at a significance level of 0.05).
13
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Average clone size (mm2) 
A
PD
18003
PD
13634
PD
20399
PD
21910
BD
C
*
*
*
